Dexamethasone Sodium Phosphate
NDC Package 0703-3524-03

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Dexamethasone Sodium Phosphate is dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye problems, breathing problems, bowel disorders, cancer, and immune system disorders. Marketed by Teva Parenteral Medicines, Inc, this product is identified by NDC 0703-3524 and is authorized under FDA application ANDA081126.

Identification & Billing

NDC Package Code
0703-3524-03
Package Description
10 VIAL, MULTI-DOSE in 1 TRAY / 1 mL in 1 VIAL, MULTI-DOSE (0703-3524-01)
Product Code
0703-3524
11-Digit Billing Format
00703352403

Clinical Specifications

Proprietary Name
Dexamethasone Sodium Phosphate
Dosage Form
-
Usage Information
Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye problems, breathing problems, bowel disorders, cancer, and immune system disorders. It is also used as a test for an adrenal gland disorder (Cushing's syndrome). Dexamethasone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. This injectable form of dexamethasone is used when a similar drug cannot be taken by mouth or when a very fast response is needed, especially in patients with severe medical conditions. Talk to your doctor about the risks and benefits of dexamethasone, especially if it is to be injected near your spine (epidural). Rare but serious side effects may occur with epidural use.

Regulatory & Marketing

Labeler Name
Teva Parenteral Medicines, Inc
FDA Application #
ANDA081126
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
08-31-1990
End Marketing Date
03-31-2011
Listing Expiration
03-31-2011
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0703-3524-03 identifies a specific commercial package of 10 vial, multi-dose in 1 tray / 1 ml in 1 vial, multi-dose (0703-3524-01) of Dexamethasone Sodium Phosphate, labeled by Teva Parenteral Medicines, Inc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Teva Parenteral Medicines, Inc on August 31, 1990. The current certification is valid through March 31, 2011.

What are the primary indications for this medication?

Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye problems, breathing problems, bowel disorders, cancer, and immune system disorders. It is also used as a test for an adrenal gland disorder (Cushing's syndrome). Dexamethasone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. This injectable form of dexamethasone is used when a similar drug cannot be taken by mouth or when a very fast response is needed, especially in patients with severe medical conditions. Talk to your doctor about the risks and benefits of dexamethasone, especially if it is to be injected near your spine (epidural). Rare but serious side effects may occur with epidural use.

How is this Teva Parenteral Medicines, Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00703352403. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0703-3524-03
11-Digit CMS (5-4-2)
00703-3524-03

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.